Tempus AI (TEM) announced the expansion of Tempus One-its generative AI clinical assistant-with direct integration into electronic health record, EHR, systems. By integrating AI at every point of the clinical care process, the expanded capabilities of Tempus One offer physicians in oncology and beyond more support in treatment decisions. Tempus One is uniquely positioned to offer these new features given the company’s depth and scale of EHR integrations with providers across the U.S.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Tempus AI announces launch of its Fuses program
- Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting
- Tempus AI Stock (TEM) Could See ‘Tesla or Nvidia-Type Inflection,’ Claims Short Seller
- Cathie Wood’s ARK Investment bought 251K shares of Tempus AI today
- AI Daily: Nvidia suppliers accelerate production of Blackwell AI server racks